Mobilat

Package Leaflet: Information for the Patient

Mobilat(0.2 g + 1.0 g + 2.0 g)/100 g, gel
(Mucopolysaccharide polysulfate + Suprarenal extract + Salicylic acid)

Read the package leaflet carefully before using the medicine, as it contains important information for the patient.

This medicine should always be used exactly as described in this package leaflet for the patient or as directed by a doctor or pharmacist.

• Keep this leaflet, you may need to read it again.
• If you need advice or additional information, consult a pharmacist.
• If there is no improvement or the patient feels worse, consult a doctor.

Table of Contents of the Leaflet

• 1. What is Mobilat and what is it used for
• 2. Important information before using Mobilat
• 3. How to use Mobilat
• 4. Possible side effects
• 5. How to store Mobilat
• 6. Contents of the pack and other information

1. What is Mobilat and what is it used for

Mobilat contains an extract from the suprarenal gland with anti-inflammatory and anti-edematous properties. This action is supported by salicylic acid, which also has analgesic effects and facilitates the penetration of biologically active components of Mobilat into tissues.
Mucopolysaccharide polysulfate has anti-inflammatory effects, reduces local blood coagulability, increases tissue perfusion, and accelerates tissue regeneration.
Indications for use:
Treatment of post-traumatic inflammatory conditions of joints and hematomas.
Treatment of pain occurring during movement and in conditions of muscle and tendon overload.

2. Important information before using Mobilat

When not to use Mobilat

If the patient is allergic to the active substance or any of the other ingredients of this medicine (listed in section 6).
The patient should inform the doctor if they have: chickenpox, post-vaccination reactions, fungal or bacterial skin infections, or other specific skin changes in the area of application (e.g., tuberculous or syphilitic changes). The doctor will decide whether the patient can use Mobilat.
The use of Mobilat in children will be decided by the doctor after assessing the benefits and risks. Do not use in children under 12 years of age without a doctor's prescription.
Patients with impaired renal function: the long-term use of Mobilat will be decided by the doctor after assessing the benefits and risks.

Warnings and precautions

Before starting to use Mobilat, discuss it with a doctor or pharmacist.
Mobilat gel should only be used on intact skin. Avoid contact between Mobilat gel and open wounds, eyes, and mucous membranes.
After applying the gel to the affected skin area, wash your hands unless they are the area being treated.

Children and adolescents

Do not use in children under 12 years of age without a doctor's prescription.

Mobilat and other medicines

Tell the doctor or pharmacist about all medicines the patient is taking or has recently taken, as well as any medicines the patient plans to use.
Salicylic acid may increase the absorption of other topical medicines. Long-term use of Mobilat on large areas of skin may lead to increased toxic effects of methotrexate and hypoglycemic effects of sulfonylurea.

Pregnancy and breastfeeding

If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult a doctor or pharmacist before using this medicine.
Mobilat should be used with caution in pregnant women.
The doctor will decide whether to use Mobilat in pregnant women after considering whether the therapeutic benefits to the mother outweigh the risks to the child. Do not use Mobilat on large areas of skin.
Do not use Mobilat in the breast area in breastfeeding women.

Driving and using machines

Mobilat does not affect the ability to drive or operate machines.
Mobilat gel contains 80 mg of propylene glycol in 1 g.Propylene glycol may cause skin irritation.

3. How to use Mobilat

This medicine should always be used exactly as described in the package leaflet for the patient or as directed by a doctor or pharmacist. If in doubt, consult a doctor or pharmacist.
The duration of use of Mobilat is determined by the doctor and depends on the type and course of the disease.
Mobilat gel is for topical use, on the skin.
Recommended dose:
Unless otherwise directed by the doctor, apply a strip of gel 5 to 15 cm long to the affected area once or three times a day. If the patient uses an occlusive dressing, the dose may be increased accordingly. After applying the gel to the affected area, gently massage it into the skin. Mobilat should be used on intact skin. Long-term use of Mobilat on large areas of skin should be done under medical supervision.

Using more than the recommended dose of Mobilat

Due to the way Mobilat is administered, overdose is unlikely.
Salicylate poisoning is possible in case of accidental ingestion of the medicine. Symptoms of poisoning include vomiting, excessive sweating, tachycardia (rapid heart rate, i.e., acceleration of heart rate above 100 beats per minute), hyperventilation (too deep and intense breathing), fever, tinnitus, disturbances of consciousness, respiratory alkalosis, and alkaline urine reaction.
Treatment: gastric lavage, monitoring of salicylate levels in blood serum, measurement of blood pH and electrolytes. Forced diuresis may be necessary.
In case of overdose symptoms, the doctor will provide appropriate symptomatic treatment.
In case of using a higher dose of Mobilat than recommended, consult a doctor.

Missing a dose of Mobilat

Do not use a double dose to make up for a missed dose. Use the medicine as directed in the package leaflet. If you have any further doubts about using this medicine, consult a doctor or pharmacist.

Stopping the use of Mobilat

Always follow the doctor's or pharmacist's instructions, who will tell the patient how long to use the medicine. The doctor will decide when to stop treatment.
If you have any further doubts about using this medicine, consult a doctor or pharmacist.

4. Possible side effects

Like all medicines, Mobilat can cause side effects, although not everybody gets them.
The following side effects have been reported:
rare (may affect up to 1 in 1,000 people)
local skin irritation
very rare (may affect up to 1 in 10,000 people)
contact allergies.

Reporting side effects

If you experience any side effects, including those not listed in the package leaflet, tell your doctor or pharmacist, or nurse. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181C
02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help to gather more information on the safety of the medicine.

5. How to store Mobilat

Keep the medicine out of the sight and reach of children.
Store in a temperature below 25°C.
Do not use this medicine after the expiry date stated on the label after: "Expiry date" or "EXP". The expiry date refers to the last day of the month.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.

6. Contents of the pack and other information

What Mobilat contains

The active substances of Mobilat are: mucopolysaccharide polysulfate, suprarenal gland extract, and salicylic acid.
Other ingredients are: disodium edetate, rosemary oil, ethanolamine, carbomer, propylene glycol, isopropyl alcohol, purified water.

What Mobilat looks like and contents of the pack

Aluminum tube internally coated with epoxyphenolic resin with a PP cap in a cardboard box containing 25 g, 50 g, or 100 g of gel.

Marketing authorization holder:

STADA Arzneimittel AG, Stadastrasse 2-18, 61118 Bad Vilbel, Germany

Manufacturer:

Mobilat Produktions GmbH, Luitpoldstrasse 1, 85276 Pfaffenhofen, Germany
STADA Arzneimittel AG, Stadastrasse 2-18, 61118 Bad Vilbel, Germany

Date of last revision of the leaflet: